Gastrointestinal effects Nausea is the most commonly reported side effect with both compounds individually
Over the last 20 years, shes lost more than 135 poundsnot without challenges
Ahmed Abdeen, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Vear A, Heneka MT, Clemmensen C (2025) Incretin-based therapeutics for the treatment of neurodegenerative diseases
And then theres this: While berberine isnt a GLP-1 receptor antagonist like semaglutide, it may promote GLP-1 production, according to a small 2021 mouse study (4)
For patients with diabetes, hypoglycemia risk increases when GLP-1 agents are combined with insulin or sulfonylureas